Regeneron says has identified antibodies to treat coronavirus

Regeneron Pharmaceuticals Inc said on Tuesday it had identified hundreds of antibodies that could potentially treat the coronavirus. The company said it will select the top two antibodies to develop a 'cocktail' treatment and that it plans to begin large-scale manufacturing of the treatment by mid-April.

Regeneron in February announced a partnership with the U.S. Department of Health and Human Services to develop a coronavirus treatment and said it would focus on monoclonal antibodies. The company is also testing its rheumatoid arthritis drug, Kevzara, with partner Sanofi SA against the virus.